Small interfering RNAs (siRNAs) silence the expression of specific target genes by
mediating RNA interference (RNAi) in mammalian cells. siRNAs have not only been widely …

RNA interference is a powerful method for the knockdown of pathologically relevant genes.
Small interfering RNAs (siRNAs) have been widely demonstrated as effective biomedical …

Concomitant with advances in research regarding the role of miRNAs in sustaining
carcinogenesis, major concerns about their delivery options for anticancer therapies have …

Since the discovery of the Nobel prize-winning mechanism of RNA interference (RNAi) ten
years ago, it has become a promising drug target for the treatment of multiple diseases …

siRNA is a promising therapeutic solution to address gene overexpression or mutations as a
post-transcriptional gene regulation process for several pathological conditions such as viral …

RNA interference holds the promise to knock down expression of every cancer gene. Both
academic laboratories and pharmaceutical companies have committed heavily on …

Cancer is one of the most complex diseases that has resulted in multiple genetic disorders
and cellular abnormalities. Globally, cancer is the most common health concern disease that …

Background: Small interfering RNA (siRNA) has become a powerful tool in knocking down
or silencing gene expression in most cells. siRNA-based therapy has shown great promise …

RNA interference currently offers new opportunities for gene therapy by the specific
extinction of targeted gene (s) in cancer diseases. However, the main challenge for nucleic …

In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug
delivery systems are based on the difference between cancer and healthy cells. Currently …